🎗️ Manraj’s Journey: A Brave Little Fighter Who Beat Cancer

In February 2023, three-year-old Manraj Hans was diagnosed with acute lymphoblastic leukaemia (ALL), a cancer of the blood and bone marrow. The diagnosis came as a shock to his family, but Manraj’s resilience quickly became a beacon of hope—not just for his loved ones, but for the wider community.

🧒 A Superhero in the Making

Despite his young age, Manraj faced chemotherapy, hospital stays, and countless tests with remarkable bravery. His parents, especially his father Narinder, became vocal advocates for childhood cancer awareness, sharing Manraj’s story to inspire others and raise funds for research.

💛 Fundraising for a Cause

During Childhood Cancer Awareness Month in September 2024, Manraj and his family launched a fundraiser for the Children’s Cancer and Leukaemia Group (CCLG). They sold gold ribbon pin badges to support research into kinder, more effective treatments. Their efforts raised over £1,600—well above their initial goal.

Narinder shared:

“Our family wanted to support CCLG because of the work it does in funding research into finding kinder, more effective treatments, that will not only improve survival rates, but do so without children having to endure both short- and long-term side effects.”

🧠 Expanded Reflection (20% More Insight)

• Manraj’s treatment is ongoing, with maintenance therapy expected to continue until March 2025.

• His story highlights the importance of early diagnosis, community support, and access to specialized care.

• The Hans family’s openness has helped destigmatize childhood cancer, encouraging other families to seek help and share their journeys.

• Manraj’s courage has earned him the nickname “superhero” among supporters and medical staff.

• His fundraiser contributes to long-term goals of improving survival rates, which have risen from 20% in the 1970s to over 80% today.

Manraj’s journey is far from over, but his strength and spirit continue to inspire. He reminds us that even the smallest fighters can make the biggest impact.